Viral hepatitis and cirrhosis.

Area of Science:

• Hepatology
• Gastroenterology

Background:

• Current understanding of post-hepatitic cirrhosis predominantly stems from recent research on hepatitis B antigen-related cases.
• The role of other hepatitis types, notably hepatitis A, as causes of cirrhosis remains uncertain.

Purpose of the Study:

• To review the characteristics and management of post-hepatitic cirrhosis.
• To highlight diagnostic and prognostic considerations, including the role of liver biopsy.
• To discuss therapeutic approaches, particularly the use of prednisolone.

Main Methods:

• Review of existing literature on post-hepatitic cirrhosis.
• Emphasis on clinical presentation, diagnosis via liver biopsy, and treatment strategies.
• Consideration of etiological factors and disease progression.

Main Results:

• Post-hepatitic cirrhosis typically arises insidiously following unrecognized acute hepatitis.
• Liver failure is a cause of early mortality, with primary hepatocellular carcinoma becoming significant later.
• Liver biopsy is crucial for diagnosis and assessing disease activity, though sampling errors are a concern.

Conclusions:

• Prednisolone may be used for symptomatic patients with confirmed active chronic hepatitis or cirrhosis, though evidence of benefit is less robust than for other forms.
• Management follows standard therapeutic guidelines for cirrhosis.
• Further research is needed to clarify the role of non-hepatitis B viral agents in cirrhosis etiology.